Zarnie Lwin, MBBS, FRACP, discusses patient selection, including those with colorectal cancer, for the phase 2 LEAP-005 study.
Zarnie Lwin, MBBS, FRACP
Advertisement
Articles by Zarnie Lwin, MBBS, FRACP
Zarnie Lwin, MBBS, FRACP, discusses the design of the phase 2 LEAP-005 trial in previously treated patients with advanced solid tumors.
Zarnie Lwin, MBBS, FRACP, discusses the results of the LEAP-005 trial in advanced solid tumors.
Advertisement
Latest Updated Articles
Dr. Lwin on the Design of the LEAP-005 Trial in Pretreated Advanced Solid TumorsPublished: October 20th 2020 | Updated:
Dr. Lwin on the Results of the LEAP-005 Trial in Advanced Solid TumorsPublished: September 20th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Approves Larger Vial Size for Nelarabine Injection in T-ALL and T-LBL
5